You are required to be logged in to access the full website
Click here if you have forgotten your username or password
6 September 2024 - Life science biotechnology company Psyence Biomedical Ltd (Nasdaq:PBM) on Friday announced plans to acquire privately-held Clairvoyant Therapeutics Inc, a clinical-stage developer of psilocybin-based therapeutics based in Canada.Th...
6 September 2024 - Clinical-stage biopharmaceutical company Ventyx Biosciences Inc (Nasdaq:VTYX) announced on Friday the start of a Phase 2a clinical trial of VTX3232, a potential treatment for early Parkinson's disease.The first patient has bee...
6 September 2024 - Indian pharmaceutical company Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) (BSE:524715) and Israel-based Moebius Medical Limited announced on Friday that the US Food and Drug Administration (FDA) has granted Fast Track des...
6 September 2024 - Clinical stage biotech company Vivet Therapeutics announced on Thursday that it has received Orphan Drug Designation (ODD) from the European Commission for the company's VTX-806, a gene therapy product intended for the treatme...
6 September 2024 - United States-based pharmaceutical and biotechnology corporation Pfizer announced on Thursday that it has named Elif Aral as its new regional president for Middle East, Russia and Africa (MERA), effective September 2024.In the new ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe